[1]李兴锐,谭悦,刘童,等.双特异性磷酸酶3和TNF-α对雷公藤多苷片治疗类风湿关节炎的预后作用及其受调节机制[J].第三军医大学学报,2019,41(01):77-84.
 LI Xingrui,TAN Yue,LIU Tong,et al.phosphatase 3 and tumor necrosis factor-α as prognostic biomarkers and their regulation by tripterygium glycosides in rheumatoid arthritis[J].J Third Mil Med Univ,2019,41(01):77-84.
点击复制

双特异性磷酸酶3和TNF-α对雷公藤多苷片治疗类风湿关节炎的预后作用及其受调节机制(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
41卷
期数:
2019年第01期
页码:
77-84
栏目:
临床医学
出版日期:
2019-01-15

文章信息/Info

Title:
phosphatase 3 and tumor necrosis factor-α as prognostic biomarkers and their regulation by tripterygium glycosides in rheumatoid arthritis
作者:
李兴锐谭悦刘童葛显应陆继娣孟林荣华东
六安市人民医院风湿免疫科
Author(s):
LI Xingrui TAN Yue LIU Tong GE Xianying LU Jidi MENG Lin

RONG HuadongDepartment of Rheumatology and Immunology, Liu’an People’s Hospital, Liu’an, Anhui Province, 237006, China

关键词:
雷公藤多苷类风湿关节炎预后因子DUSP3TNF-&alpha
Keywords:
tripterygium glycosides rheumatoid arthritis prognostic factors dual specificity protein phosphatase 3 tumor necrosis factor-&alpha
分类号:
R285.6; R392.5; R593.22
文献标志码:
A
摘要:

目的   探讨双特异性磷酸酶3(dual specificity protein phosphatase 3,DUSP3)和TNF-α作为雷公藤多苷(tripterygium glycosides,TG)片治疗类风湿关节炎(rheumatoid arthritis,RA)预后生物标记物的可行性和调节机制。方法    选取本院于2016年3月至2018年1月收治的67例RA患者及67例健康志愿者,RT-PCR检测治疗前后外周血单个核细胞(peripheral blood mononuclear cells,PBMC)中DUSP3和TNF-α表达,并进行ROC分析。以TG处理脂多糖刺激的U937细胞,模拟TG片治疗RA,通过RT-PCR、Western blot和免疫共沉淀实验检测DUSP3和TNF-α之间的关系,及其上下游通路。结果    与健康志愿者相比,RA患者(用药前)PBMC中DUSP3表达降低而TNF-α表达升高(P<0.05)。TNF-α和DUSP3进行ROC分析的AUC分别为0.948和0.908。治疗后RA患者DAS28,ESR和CRP值下降,DUSP3和TNF-α表达分别升高和降低(P<0.05)。TG片用药响应和不响应(骨侵蚀指标)的RA患者的DUSP3和TNF-α表达水平差异显著(P<0.05)。以用药后DAS28表达变化区分RA患者是否响应TG片治疗,ROC分析显示DUSP3和TNF-α的AUC分别为0.821和0.747。在LPS刺激的U937细胞中,改变DUSP3或TNF-α表达不相互影响表达。Western blot结果显示NF-κB介导TG对TNF-α调节。ChIP结果证实TG抑制了HDAC1与DUSP3启动子区相互作用。Western blot结果表明TG给药抑制了LPS诱导的HDAC1上调和DUSP3下调。结论   TG片对RA有较好的治疗效果。其中,DUSP3和TNF-α可以作为TG片治疗RA的预后因子。TG给药降低了TNF-α的表达,并解除了对DUSP3的抑制。

Abstract:

Objective   To investigate the prognostic value of dual specificity protein phosphatase 3(DUSP3) and tumor necrosis factor-α(TNF-α) and how tripterygium glycosides(TG) regulate DUSP3 and TNF-α expression in patients with rheumatoid arthritis(RA). Methods     A total of 67 patients with RA receiving treatment with TG tablets in our hospital between March, 2016 and January, 2018 and 67 healthy volunteers were enrolled in this study. The expression of DUSP3 and TNF-α in the peripheral blood mononuclear cells(PBMCs) of the participants was detected using real-time PCR(RT-PCR), and the results were analyzed using the receiver operating curve(ROC). In U937 cells stimulated with lipopolysaccharide(LPS), the effects of TG on the expressions of DUSP3, TNF-α and their upstream and downstream pathways were investigated using RT-PCR, Western blotting and chromatin immunoprecipitation(ChIP). Results    Compared with the healthy volunteers, the RA patients showed significantly reduced DUSP3 expression and increased TNF-α expression in the PBMCs(P<0.05), whose areas under the curve(AUC) were 0.948 and 0.908, respectively. Treatment with TG tablets resulted in significantly decreased 28-joint Disease Activity score(DAS28), erythrocyte sedimentation rate(ESR) and C-reactive protein(CRP), increased expression of DUSP3 and decreased TNF-α expression in the RA patients(P<0.05). Significant differences were found in the expression of DUSP3 and TNF-α between the RA patients who responded to the treatment and the non-responding patients(with bone erosion,P<0.05). ROC analysis showed that the AUC of DUSP3 and TNF-α was 0.821 and 0.747, respectively, for predicting the patients’ response to TG treatment(defined by the changes in DAS28). In LPS-stimulated U937 cells, the changes in DUSP3 or TNF-α expression did not affect the expression of one another. The rescue experiments demonstrated that nuclear factor-κB(NF-κB) mediated the inhibitory effect of TG on TNF-α expression. ChIP experiments confirmed that TG suppressed the conjugation of HDAC1 with DUSP3 promoter; Western blotting showed that TG inhibited LPS-induced up-regulation of HDAC1 and down-regulation of DUSP3. Conclusion    TG tablet produces good therapeutic effect on RA by reducing the expression of TN-α and relieving the inhibition on DUSP3. DUSP3 and TNF-α can serve as prognostic biomarkers for RA patients receiving treatment with TG tablets.

参考文献/References:

[1]SCOTT D L, WOLFE F, HUIZINGA T W. Rheumatoid arthritis[J]. Lancet, 2010, 376(9746):1094-1108.DOI:10.1016/S01406736(10)608264.
[2]SMOLEN J S, ALETAHA D, BARTON A, et al. Rheumatoid arthritis[J]. Nat Rev Dis Primers, 2018, 4:18001. DOI:10.1038/nrdp.2018.1.
[3]ALAM J, JANTAN I, BUKHARI S N A. Rheumatoid arthritis: Recent advances on its etiology, role of cytokines and pharmacotherapy[J]. Biomed Pharmacother, 2017, 92:615-633. DOI:10.1016/j.biopha.2017.05.055.
[4]FAN D, GUO Q, SHEN J, et al. The effect of triptolide in rheumatoid arthritis: from basic research towards clinical translation[J]. Int J Molecular Sci, 2018, 19(376):1-17. DOI:10.3390/ijms19020376.
[5]LIU S P, WANG G D, DU X J, et al. Triptolide inhibits the function of TNF-α in osteoblast differentiation by inhibiting the NF-κB signaling pathway[J]. Exp Ther Med, 2017, 14: 2235-2240.DOI: 10.3892/etm.2017.4749.
[6]VAN HAMBURG J P, TASS W. Molecular mechanisms underpinning T helper 17 cell heterogeneity and functions in rheumatoid arthritis[J]. J Autoimmun, 2018, 87:69-81. DOI:10.1016/j.jaut.2017.12.006.
[7]PALA O, DIAZ A, BLOMBERG B B, et al. B lymphocytes in rheumatoid arthritis and the effects of antiTNFalpha agents on B lymphocytes: a review of the literature[J]. Clin Ther, 2018, 40(6):1034-1045. DOI:10.1016/j.clinthera.2018.04.016.
[8]ROSSOL M, SCHUBERT K, MEUSCH U, et al. Tumor necrosis factor receptor type I expression of CD4+ T cells in rheumatoid arthritis enables them to follow tumor necrosis factor gradients into the rheumatoid synovium[J]. Arthritis Rheum, 2013, 65(6):1468-1476. DOI:10.1002/art.37927.
[9]王贵, 郭明慧, 徐慧慧,等. 雷公藤甲素对高迁移率族蛋白1诱导的破骨细胞分化的影响[J]. 中日友好医院学报, 2017, 31(2):102-106. DOI: 10.3969/j.issn.1001-0025.2017.02.010.
WANG G, GUO M H, XU H H, et al. The effect of triptolide on differentiation of osteoclasts induced by HMGB1[J]. J ChinaJapan Friendship Hosp,  2017, 31(2):102-106. DOI: 10.3969/j.issn.1001-0025.2017.02.010.
[10]PAUNOVIC V, HARNETT M M. Mitogenactivated protein kinases as therapeutic targets for rheumatoid arthritis[J].Drugs,2013,73(2):101-115. DOI:10.1007/s40265-013-0014-6.
[11]王建竹,连金饶,孔祥英,等.雷公藤甲素对TNFα诱导的滑膜细胞增殖的影响及对Ras-MAPKs信号转导通路的调控作用[J].中国中药杂志,2010,35(7):888-891.DOI:10.4268/cjcmm20100719.
WANG J Z, LIAN J R, KONG X Y, et al. Effects of triptolide on cell proliferation and regulation of RasMAPKs pathway in synoviocytes induced by tumor necrosis factor[J].China J Chin Materia Med, 2010, 35(7):888-891.DOI:10.4268/cjcmm20100719.
[12]CERIGNOLI F, RAHMOUNI S, RONAI Z, et al. Regulation of MAP kinases by the VHR dualspecific phosphatase: implications for cell growth and differentiation[J]. Cell Cycle, 2006, 5(19):2210-2215. DOI:10.4161/cc.5.19.3267.
[13]SHARP J T, YOUNG D Y, BLUHM G B,et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?[J]. Arthritis Rheum,1985,28(12):1326-1335.
[14]FAN D, GUO Q, SHEN J, et al. The effect of triptolide in rheumatoid arthritis: from basic research towards clinical translation[J]. Int J Mol Sci, 2018, 19(2):E376. DOI:10.3390/ijms19020376.
[15]REDLICH K, HAYER S, MAIER A, et al. Tumor necrosis factor alphamediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin[J]. Arthritis Rheum, 2002, 46(3):785-792. DOI:10.1002/art.10097.
[16]TANAKA K, ODA N, IWASAKA C, et al. Induction of Ets1 in endothelial cells during reendothelialization after denuding injury[J]. J Cell Physiol, 1998, 176(2):235-244. DOI:10.1002/(SICI)10974652(199808)176:2<235::AIDJCP2>3.0.CO;2P.
[17]GUMPENA R, LOUNTOS G, RARANKURUSSI S, et al. Crystal structure of the human dual specificity phosphatase 1 catalytic domain[J]. Protein Sci, 2018, 27(2): 561-567. DOI: 10.1002/pro.3328.
[18]HAWTREE S, MUTHAN A M, WILSON A G. The role of histone deacetylases in rheumatoid arthritis fibroblastlike synoviocytes[J]. Biochem Soc Trans, 2013, 41(3): 783-788. DOI:10.1042/BST20130053.
[19]GRABIEC A M, REEDQUIST K A. Histone deacetylases in RA: epigenetics and epiphenomena[J]. Arthritis Res Ther, 2010, 12(5): 142. DOI:10.1186/ar3137.
[20]HAWTREE S, MUTHANA M, WILKINSONJ M, et al. Histone deacetylase 1 regulates tissue destruction in rheumatoid arthritis[J]. Hum Mol Genet, 2015, 24(19): 5367-5377. DOI:10.1093/hmg/ddv258.
[21]BUCKLAND J. Rheumatoid arthritis: HDAC and HDACi: pathogenetic and mechanistic insights[J]. Nat Rev Rheumatol, 2011, 7(12): 682. DOI:10.1038/nrrheum.2011.162.
[22]CHOO Q Y, HO P C, TANAKA Y, et al. The histone deacetylase inhibitors MS275 and SAHA suppress the p38 mitogenactivated protein kinase signaling pathway and chemotaxis in rheumatoid arthritic synovial fibroblastic E11 cells[J]. Molecules, 2013, 18(11): 14085-14095. DOI:10.3390/molecules181114085.
[23]HOYT R, ZHU W, CERIGNOLI F, et al. Cutting edge: selective tyrosine dephosphorylation of interferonactivated nuclear STAT5 by the VHR phosphatase[J]. J Immunol, 2007, 179(6): 3402-3406.
[24]TAMBE M B, NARVI EKALLIO M. Reduced levels of Dusp3/Vhr phosphatase impair normal spindle bipolarity in an Erk1/2 activitydependent manner[J]. FEBS Letters, 2016, 590(16): 2757-2767. DOI:10.1002/18733468.12310.
[25]VANDEREYKEN M, JACQUES S, VAN OVERMEIRE E, et al. Dusp3 deletion in mice promotes experimental lung tumour metastasis in a macrophage dependent manner[J]. PLoS ONE, 2017, 12(10): e0185786. DOI:10.1371/journal.pone.0185786.
[26]AMAND M, ERPICUM C, BAJOU K, et al. DUSP3/VHR is a proangiogenic atypical dualspecificity phosphatase[J]. Mol Cancer, 2014, 13(108):1-18. DOI: 10.1186/1476-4598-13-108.
[27]CHEN Y, CHOU H, YANG C, et al. Deficiency in VHR/DUSP3, a suppressor of focal adhesion kinase, reveals its role in regulating cell adhesion and migration[J]. Oncogene, 2017, 36(47): 6509-6517. DOI: 10.1038/onc.2017.255.
[28]TOH M L, YANG Y, LEECH M, et al. Expression of mitogenactivated protein kinase phosphatase 1, a negative regulator of the mitogenactivated protein kinases, in rheumatoid arthritis: upregulation by interleukin1beta and glucocorticoids[J]. Arthritis Rheum, 2004, 50(10):3118-3128. DOI:10.1002/art.20580.

相似文献/References:

[1]万萍,钟兵,邹庆华,等.类风湿关节炎早期诊断指标的筛选及鉴定[J].第三军医大学学报,2012,34(15):1564.
 Wan Ping,Zhong Bing,Zou Qinhua,et al.Manganese superoxide dismutase: an early diagnostic marker for rheumatoid arthritis[J].J Third Mil Med Univ,2012,34(01):1564.
[2]柏干苹,周丽娜,贺伟峰,等.类风湿关节炎患者滑膜成纤维细胞的差异蛋白质谱分析[J].第三军医大学学报,2008,30(02):166.
 BO Gan-ping,ZHOU Li-na,HE Wei-feng,et al.Differential proteome of human synovial fibroblasts from rheumatoid arthritis patients[J].J Third Mil Med Univ,2008,30(01):166.
[3]吴建红,魏洪兵,姚朝群.来氟米特治疗类风湿关节炎的临床研究[J].第三军医大学学报,2007,29(03):274.
[4]柏干苹,周丽娜,贺伟峰,等.双向电泳-质谱法寻找类风湿关节炎疾病相关蛋白[J].第三军医大学学报,2006,28(07):726.
[5]王雯,陈森洲,王险峰,等.HIF-1α、VEGF在CIA大鼠模型中的表达与意义[J].第三军医大学学报,2010,32(06):563.
 Wang Wen,Chen Senzou,Wang Xianfen,et al.Expression and significance of HIF-1α and VEGF in rats with collagen Ⅱ-induced arthritis[J].J Third Mil Med Univ,2010,32(01):563.
[6]夏璇,肖敬,黄清春.类风湿关节炎合并膜性肾病1例[J].第三军医大学学报,2010,32(17):1907.
[7]李景怡,方勇飞,邹丽云,等.Th1/Th2细胞因子谱在类风湿关节炎患者外周血和关节积液中的表达及意义[J].第三军医大学学报,2010,32(18):1921.
 Li Jingyi,Fang Yongfei,Zou Liyun,et al.Th1/Th2 cytokines’ profile in peripheral blood and synovial fluid of patients with rheumatoid arthritis[J].J Third Mil Med Univ,2010,32(01):1921.
[8]尉世同,孙永华,邹巧菲,等.双醋瑞因联合甲氨喋呤治疗类风湿关节炎的临床研究[J].第三军医大学学报,2010,32(19):2112.
 Wei Shitong,Sun Yonghua,Zou Qiaofei,et al.Combined diacerein and methotrexate in treatment of rheumatoid arthritis: report of 120 cases[J].J Third Mil Med Univ,2010,32(01):2112.
[9]刘青松,朱兴春,邢艳,等.丹参诱导类风湿关节炎患者成纤维样滑膜细胞中Fas/FasL的表达[J].第三军医大学学报,2010,32(22):2452.
[10]李静,柏干苹,王勇,等.401例类风湿关节炎患者中医证候要素分析[J].第三军医大学学报,2009,31(21):2103.
 LI Jing,BAI Gan-ping,WANG Yong,et al.Analysis on traditional Chinese medicine syndroms of 401 rheumatoid arthritis patients[J].J Third Mil Med Univ,2009,31(01):2103.

更新日期/Last Update: 2019-01-14